July 24 (Reuters) - U.S. regulators have accepted an application by Sandoz - the generics arm of Novartis - seeking approval for a copycat version of Amgen's drug Neupogen, or filgrastim, for...
the red, weighed down by losses in Boeing. Biotech stocks rallied after a big earnings beat from Biogen and positive trial results from Puma Biotech , which helped push the Nasdaq Biotech ETF up 2.2%. The broader Nasdaq also drew
been controversial among investors. Generally, 2014 has been a year in which this still small cap, still early-stage biotechnology company has seen some recognition, driving its market cap up to the $700 million range. On Wednesday, July 23, 2014
difference a week can make. Last Tuesday, biotech stocks were selling off on Janet Yellen's ..... about the valuation levels of smaller biotech and social media names calling them ..... substantially stretched." Her comments sent the Biotech Index and bellwethers like Biogen (NASDAQ
biotechs, particularly during February (10 biotech IPOs) and March (10). Assuming every biotech on the IPO calendar for July actually prices ..... public this month, a sharp spike from the 38 biotech IPOs in the first half of the year. Biotechs
NASDAQ: GILD ) is set to report FQ2 2014 earnings after the market closes on Wednesday, July 23rd. Gilead Sciences is a biotechnology company that throughout its history has primarily focused on antiviral drugs to treat infections such as HIV and hepatitis
firm also has a HER2 inhibitor (ONT-380) in development. Investors are falling all over themselves to buy into Puma Biotechnology ( PBYI +292.5% ) after it announced positive results from a Phase 3 clinical trial evaluating its HER2 inhibitor PB272
over this time period. Biotech was one of the areas we ..... such as the SPDR S&P Biotech ETF (NY XBI ) and the iShares Nasdaq Biotechnology (NASDAQ: IBB ) with our ..... preference being the SPDR S&P Biotech due to it having less exposure
The Beijing Centers for Disease Control and Prevention selects Sinovac Biotech Ltd. ( SVA +1% ) as one of four suppliers of influenza vaccines to the citizens of Beijing for 2014. Each manufacturer will
PharmaRoth Labs ( OTCPK:ROTH ) signs a distribution agreement with Tianjin Leading Biotechnology Co. Ltd. for the sale and marketing of Sucanon in China. Financial terms are not disclosed. Post your comment!